Droufakou et al. studied 22 ILCs employing methylation-specific PCR and found that 17/22 (77%) of the specimens “had methylation of the CDH1 promotor, including 11/12 (91%) of E-cadherin-negative tumours.” This interesting statement from the abstract hinted (unwillingly)? This evidence concerns the gene CDH1 and neoplasm.